î
îŒ
î
Foxo Technologies Inc
FOXO0.092USD
0.000
çµå€Â 12/24, 13:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
31.56Kæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± Foxo Technologies Inc äŒæ¥å
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Foxo Technologies Incã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãFOXO
äŒç€ŸåFoxo Technologies Inc
äžå Žæ¥Dec 11, 2020
æé«çµå¶è²¬ä»»è
ãCEOãMr. Seamus Lagan
åŸæ¥å¡æ°- -
蚌åžçš®é¡Ordinary Share
決ç®ææ«Dec 11
æ¬ç€Ÿæåšå°477 South Rosemary Avenue
éœåžWEST PALM BEACH
蚌åžååŒæUS 'Other OTC' and Grey Market
åœUnited States of America
éµäŸ¿çªå·33401
é»è©±çªå·16128000059
ãŠã§ããµã€ãhttp://delwinds.com/
äŒæ¥ã³ãŒãFOXO
äžå Žæ¥Dec 11, 2020
æé«çµå¶è²¬ä»»è
ãCEOãMr. Seamus Lagan
Foxo Technologies Incã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.60%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.60%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Thu, Dec 4
æŽæ°æå»: Thu, Dec 4
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Rennova Health, Inc.
0.07%
Kr8 ai Inc
0.02%
ä»ã®
99.92%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Rennova Health, Inc.
0.07%
Kr8 ai Inc
0.02%
ä»ã®
99.92%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Corporation
0.08%
ä»ã®
99.92%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Oct 1
æŽæ°æå»: Wed, Oct 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q3
34
103.47K
0.13%
+57.49K
2025Q2
43
122.62K
2.30%
-40.72K
2025Q1
44
283.42K
16.93%
-74.76K
2024Q4
45
2.97M
12.59%
-305.11K
2024Q3
42
2.93M
22.70%
-1.57M
2024Q2
66
3.17M
26.93%
-1.03M
2024Q1
108
4.13M
45.76%
-1.73M
2023Q4
115
3.33M
41.62%
-1.13M
2023Q3
119
2.33M
33.97%
-1.67M
2023Q2
124
2.96M
79.90%
-804.39K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Rennova Health, Inc.
51.44K
0.07%
+2.00
+0.00%
Sep 10, 2025
Kr8 ai Inc
11.91K
0.02%
+1.00
+0.01%
Sep 10, 2025
Corbin Capital Partners, L.P.
1.38K
0%
--
--
Dec 31, 2024
Atalaya Capital Management LP
592.00
0%
--
--
Jun 30, 2024
Barnes (Bret)
168.00
0%
+1.00
+0.60%
Sep 10, 2025
詳现ãèŠã
é¢é£ETF
îéæå
æ¯ç
ããŒã¿ãªã
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
çš®é¡
æ¯ç
Nov 15, 2024
Merger
0â0
Oct 30, 2023
Merger
10â1
Oct 30, 2023
Merger
10â1
Oct 30, 2023
Merger
10â1
Oct 30, 2023
Merger
10â1
æ¥ä»
çš®é¡
æ¯ç
Nov 15, 2024
Merger
0â0
Oct 30, 2023
Merger
10â1
Oct 30, 2023
Merger
10â1
Oct 30, 2023
Merger
10â1
Oct 30, 2023
Merger
10â1
ãããã質å
Foxo Technologies Incã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îFoxo Technologies Incã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ãã
Rennova Health, Inc.ã¯51.44Kæ ªãä¿æããŠãããããã¯å šäœã®0.07%ã«çžåœããŸãã
Kr8 ai Incã¯11.91Kæ ªãä¿æããŠãããããã¯å šäœã®0.02%ã«çžåœããŸãã
Corbin Capital Partners, L.P.ã¯1.38Kæ ªãä¿æããŠãããããã¯å šäœã®0.00%ã«çžåœããŸãã
Atalaya Capital Management LPã¯592.00æ ªãä¿æããŠãããããã¯å šäœã®0.00%ã«çžåœããŸãã
Barnes (Bret)ã¯168.00æ ªãä¿æããŠãããããã¯å šäœã®0.00%ã«çžåœããŸãã
Rennova Health, Inc.ã¯51.44Kæ ªãä¿æããŠãããããã¯å šäœã®0.07%ã«çžåœããŸãã
Kr8 ai Incã¯11.91Kæ ªãä¿æããŠãããããã¯å šäœã®0.02%ã«çžåœããŸãã
Corbin Capital Partners, L.P.ã¯1.38Kæ ªãä¿æããŠãããããã¯å šäœã®0.00%ã«çžåœããŸãã
Atalaya Capital Management LPã¯592.00æ ªãä¿æããŠãããããã¯å šäœã®0.00%ã«çžåœããŸãã
Barnes (Bret)ã¯168.00æ ªãä¿æããŠãããããã¯å šäœã®0.00%ã«çžåœããŸãã
Foxo Technologies Incã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯äœã§ããïŒ
îFoxo Technologies Incã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯ã
Rennova Health, Inc.
Kr8 ai Inc
ä»ã®
Rennova Health, Inc.
Kr8 ai Inc
ä»ã®
Foxo Technologies IncïŒFOXOïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2025Q3æç¹ã§ãFoxo Technologies Incã®æ ªåŒãä¿æããŠããæ©é¢ã¯34瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ103.47Kã§ãå
šäœã®0.13%ãå ããŠããŸãã2025Q2ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯-2.16%å¢å ããŠããŸãã
Foxo Technologies Incã®æ倧ã®åçæºã¯äœã§ããïŒ
î--ã«ãããŠã--éšéãFoxo Technologies Incã«ãšã£ãŠæ倧ã®åçãçã¿åºããŠããããã®éé¡ã¯--ã§ãå
šåçã®--%ãå ããŠããŸãã
